Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now includes Melanoma as a related topic and adds a MedlinePlus Genetics section under related topics. These additions provide quick access to melanoma-related information and genetics resources without changing the study details.
    Difference
    0.2%
    Check dated 2026-05-25T06:26:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3. This change represents an update to the site's deployment version rather than study-related content.
    Difference
    0.1%
    Check dated 2026-05-18T03:47:34.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Deletes the Melanoma disease reference and the related topics header and MedlinePlus Genetics link from the page. This changes how readers interpret the study focus and locate related background resources.
    Difference
    0.2%
    Check dated 2026-05-11T01:31:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.0 to v3.5.3, indicating a site or release update rather than a change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-26T15:40:04.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic, and MedlinePlus Genetics is listed under related topics to provide disease context and educational resources.
    Difference
    0.2%
    Check dated 2026-04-05T07:26:28.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Removed the core disease term 'Melanoma' and related topics; this reduces essential context for the study and may affect how users understand and locate the page.
    Difference
    0.2%
    Check dated 2026-03-21T20:28:02.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.